Participants will be consented to participate prior to study
interventions.
Blood samples (10ml each) will be drawn sequentially throughout
pregnancy beginning at 24 weeks at antenatal care visits throughout
the pregnancy. The goal is to obtain between 3 and 5 blood samples
before delivery. A final sample will be drawn at the 6 week
postpartum visit, or at a time and place convenient for the
participant. These samples will be analyzed in the Gaudilliere lab at
Stanford using CYTof technology. An interim analysis of these samples
will be conducted after 20 participants have completed the study to
optimize the analysis of the remaining 60 participants. Enrollment
will continue throughout this period.
In addition to blood samples we will collect basic demographic data,
obstetric and general health history information, delivery data for
the current pregnancy, and general information on the health of the
delivered infant.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.